Analysts have raised their price target for FIGS from $6.42 to $6.74, citing ongoing strength in U.S. healthcare apparel demand and a solid, debt-free balance sheet as supporting factors for the positive adjustment.
Analyst Commentary
Recent analyst coverage of FIGS has highlighted both encouraging trends and ongoing areas of caution regarding the company's growth trajectory and valuation. The following summarizes key perspectives from recent research notes:
Bullish Takeaways- Bullish analysts are encouraged by sustained demand trends in the U.S. healthcare apparel market, which support ongoing revenue strength for FIGS.
- The company’s debt-free balance sheet and prudent financial management are frequently cited as positive factors that reduce risk and strengthen its position for future investments.
- Strong brand recognition and momentum suggest that FIGS remains well-positioned to extend market share and deliver upside as the healthcare apparel market continues to expand.
- Solid execution, including successful product strategies and effective management engagement, has led to better-than-expected results and optimism that this momentum could carry through the remainder of 2025.
- Bearish analysts caution that the company’s outlook incorporates periods of softer demand. There is concern that fewer promotions and reduced discounting may impact sales growth later in the year.
- There are concerns that current valuation reflects much of the expected growth, potentially limiting near-term upside for investors entering at these price levels.
- Some analysts observe that the market has already priced in FIGS's operational strengths, which may make it harder for future outperformance to be rewarded in the stock price.
What's in the News
- FIGS, Inc. completed its previously announced share buyback, repurchasing a total of 9,872,547 shares, equivalent to 5.83% of the company, for $48.01 million. No shares were repurchased in the most recent quarter. (Key Developments)
- The company updated its earnings guidance for 2025 and projects net revenues to grow in the low-single-digits compared to 2024. (Key Developments)
Valuation Changes
- Consensus Analyst Price Target has risen slightly from $6.42 to $6.74. This reflects a modest increase in expected fair value.
- Discount Rate has increased marginally from 8.43% to 8.50%.
- Revenue Growth projections remain effectively unchanged at 4.86%.
- Net Profit Margin expectations are stable, holding at approximately 5.64%.
- Future P/E multiple has edged up from 32.05x to 33.72x. This indicates a modest expansion in valuation expectations.
Disclaimer
AnalystConsensusTarget is a tool utilizing a Large Language Model (LLM) that ingests data on consensus price targets, forecasted revenue and earnings figures, as well as the transcripts of earnings calls to produce qualitative analysis. The narratives produced by AnalystConsensusTarget are general in nature and are based solely on analyst data and publicly-available material published by the respective companies. These scenarios are not indicative of the company's future performance and are exploratory in nature. Simply Wall St has no position in the company(s) mentioned. Simply Wall St may provide the securities issuer or related entities with website advertising services for a fee, on an arm's length basis. These relationships have no impact on the way we conduct our business, the content we host, or how our content is served to users. The price targets and estimates used are consensus data, and do not constitute a recommendation to buy or sell any stock, and they do not take account of your objectives, or your financial situation. Note that AnalystConsensusTarget's analysis may not factor in the latest price-sensitive company announcements or qualitative material.